MIRA INFORM REPORT

 

 

Report Date :

21.05.2013

 

IDENTIFICATION DETAILS

 

Name :

TAE CHANG INDUSTRIAL CO., LTD.

 

 

Registered Office :

691-4, Boheung-ri, Useong-myeon, Gongju-si, Chungcheongnam-do, Korea 314-864

 

 

Country :

South Korea

 

 

Financials (as on) :

31.12.2011

 

 

Date of Incorporation :

06.08.2007

 

 

Com. Reg. No.:

307-81-26201

 

 

Legal Form :

Co., Ltd by Shares

 

 

Line of Business :

Manufacture of Other Medical and Surgical Equipment and Orthopedic Appliances n.e.c.

 

 

No. of Employees :

105

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

South Korea

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

SOUTH KOREA - ECONOMIC OVERVIEW

 

South Korea over the past four decades has demonstrated incredible growth and global integration to become a high-tech industrialized economy. In the 1960s, GDP per capita was comparable with levels in the poorer countries of Africa and Asia. In 2004, South Korea joined the trillion dollar club of world economies, and is currently the world's 12th largest economy. Initially, a system of close government and business ties, including directed credit and import restrictions, made this success possible. The government promoted the import of raw materials and technology at the expense of consumer goods, and encouraged savings and investment over consumption. The Asian financial crisis of 1997-98 exposed longstanding weaknesses in South Korea's development model including high debt/equity ratios and massive short-term foreign borrowing. GDP plunged by 6.9% in 1998, and then recovered by 9% in 1999-2000. Korea adopted numerous economic reforms following the crisis, including greater openness to foreign investment and imports. Growth moderated to about 4% annually between 2003 and 2007. Korea's export focused economy was hit hard by the 2008 global economic downturn, but quickly rebounded in subsequent years, reaching 6.3% growth in 2010. The US-South Korea Free Trade Agreement was ratified by both governments in 2011 and went into effect in March 2012. Throughout 2012 the economy experienced sluggish growth because of market slowdowns in the United States, China, and the Eurozone. The incoming administration in 2013, following the December 2012 presidential election, is likely to face the challenges of balancing heavy reliance on exports with developing domestic-oriented sectors, such as services. The South Korean economy's long term challenges include a rapidly aging population, inflexible labor market, and heavy reliance on exports - which comprise half of GDP.

Source : CIA

Basic Information

 

Basic

 

Company Name

TAE CHANG INDUSTRIAL CO., LTD.

Registered Address

691-4, Boheung-ri, Useong-myeon, Gongju-si, Chungcheongnam-do, Korea

Zip Code

314-864

Tel

+82-41-854-7422

Fax

+82-41-852-7004

E-mail

taechang@kornet.net;tcind@needles.co.kr

Website

www.tcneedles.com;www.needles.co.kr

Trading Address

691-4, Boheung-ri, Useong-myeon, Gongju-si, Chungcheongnam-do, Korea

Tel

+82-41-854-7422

Fax

+82-41-852-7004

Other Address-Factory

293-2, Gongdan 2-dong, Gumi-si, Gyeongsangbuk-do, Korea

Tel

+82-54-461-5591

Fax

+82-54-461-5594

Other Address-Office

Hanshin Intervalley 24 East Bldg., 707-34, Yeoksam 2-dong, Gangnam-gu, Seoul, Korea

Tel

+82-2-2183-1155

Fax

+82-2-2183-1154

Type

Export/Import

Industry

Manufacture of Other Medical and Surgical Equipment and Orthopedic Appliances n.e.c.

  Main Business

Disposable Needle, Spinal Needle

Established (mm/dd/yyyy)

06/08/2007

 

 

Detailed Products

 

Activity

Detailed Products (UNSPSC)

Sell

Injection and aspiration needles and accessories(42142500)

 

 

CEO’s

 

Name

In Jung-Ryun

Address

A-4602, 56, Eonju-ro 30-gil, Gangnam-gu, Seoul, Korea

Date of Birth

09/08/1956

Title

Representative Director

Sex

Male

Nationality

Canadian

 

 

Profiles

 

Capital (KRW)

50,000,000

Employees

105

Formation

Co., Ltd by Shares

Bank Details

Citibank, Korea

Corporate Registered No.

1612110-018325

Business Registered No.

307-81-26201

Permit & Licenses

01/05/2004 CE,ISO9001:2000

01/05/2004 ISO 13488:1996(SGS No. GB04/60714-60716)

Shareholder Position

N/A

Company History

06/1991 Established as TAE CHANG INDUSTRIAL CO.(Sole Proprietorship)

06/08/2007 Incorporated as the present name

 

 

 

 

Detailed Information

 

Management

 

Job Description

Title

Name

Sex

Nationality

Inauguration Date

Representative Director

Mr.

In Jung-Ryun

Male

Canadian

06/08/2010

 

Financials

 

Year / Unit : KRW

Sales

Assets

Net Income

2012

 

 

 

2011

11,225,000,000

7,704,000,000

826,000,000

2010

10,003,000,000

6,958,000,000

942,000,000

2009

10,161,000,000

4,542,000,000

689,000,000

2008

 

 

 

2007

 

 

 

2006

 

 

 

2005

 

 

 

2004

 

 

 

2003

 

 

 

The latest & full financials are not available, and the Subject Company does not have any obligations to release its financials to the public.

 

 

Financial Description

 

Authorized Capital(KRW)

200,000,000

Paid-Up Capital(KRW)

50,000,000

Total Issued Shares

10,000

 

Balance Sheet

Unit : Korean Won

As of 12/31/2011

As of 12/31/2010

As of 12/31/2009

Total Assets

7,704,000,000

6,958,000,000

4,542,000,000

Current Assets

3,343,000,000

3,217,000,000

1,411,000,000

-Quick Assets

-

-

-

-Inventories

-

-

-

Fixed Assets

4,361,000,000

3,741,000,000

3,131,000,000

-Investment

-

-

-

-Tangibles

-

-

-

-Intangibles

-

-

-

Total Liabilities

4,732,000,000

4,796,000,000

3,363,000,000

Current Liabilities

4,158,000,000

4,556,000,000

3,313,000,000

Fixed Liabilities

574,000,000

240,000,000

50,000,000

Capital Stock

50,000,000

50,000,000

50,000,000

Capital Surplus

-

-

-

Profit Surplus

-

-

-

Capital Adjustment

-

-

-

Total Equity

2,971,000,000

2,162,000,000

1,179,000,000

Liab. & Shareholder’s Equity

7,703,000,000

6,958,000,000

4,542,000,000

 

Income Statement

Unit : Korean Won

As of 12/31/2011

As of 12/31/2010

As of 12/31/2009

Sales

11,225,000,000

10,003,000,000

10,161,000,000

Cost of Sold Goods

8,963,000,000

7,538,000,000

8,390,000,000

Gross Profit

2,262,000,000

2,465,000,000

1,771,000,000

Selling & Admin. Expenses

1,265,000,000

1,394,000,000

970,000,000

Operating Income

997,000,000

1,071,000,000

801,000,000

Non-Operating Income

142,000,000

120,000,000

232,000,000

Non-Operating Expenses

125,000,000

113,000,000

139,000,000

Income Before Taxes

1,014,000,000

1,078,000,000

895,000,000

Income Taxes Expenses

188,000,000

136,000,000

206,000,000

Net Income

826,000,000

942,000,000

689,000,000

 

 

Products, Technologies, Services Description

 

Main Products & Services

Cannula

Bulk Needle

Sterile Needle

Spinal Needle

Epidural Needle

Dental Needle

Pen Needle

Insulin

Detailed Products Spec.

 

Technologies Acquired

 

 

Trade Partners & Competitors

 

Suppliers

 

Customers

 

Competitors

KIM INTERNATIONAL

193-55, MASEOGU-RI, HWADO-EUP, NAMYANGJU-SI, GYEONGGI-DO, KOREA

TEL:+82-31-593-8716  FAX:+82-31-593-8715

 

BECTON DICKINSON KOREA LTD.

293-2, GONGDAN 2-DONG, GUMI-SI, GYEONGSANGBUK-DO, KOREA

TEL:+82-54-461-5591  FAX:+82-54-461-5594

 

SHINA CORPORATION

691-1, BOHEUNG-RI, USEONG-MYEON, GONGJU-SI, CHUNGCHEONGNAM-DO, KOREA

TEL:+82-41-853-0871  FAX:+82-41-853-0872

 

 

Sales by Region (Activity & Markets)

 

Sales/ Unit :Mil KRW

2012

2011

2010

Export

 

 

 

Domestic

 

 

 

Total

 

 

 

The Subject exports to Argentina, Peru, USA, Japan, China, Singapore, India and Germany.

 

 

News Clipping

 

Not Available.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.04

UK Pound

1

Rs.83.61

Euro

1

Rs.70.68

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.